Further, we identified and characterized a novel lncRNA, ENST00000449248.1 (PRADX) that was found to be upregulated in glioblastoma (GBM) and colon adenocarcinoma (COAD), and predominantly localized in the nucleus of tumor cells. Here, PRADX is linked to neoplasm.